References
O'Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine resistant septic shock. Lancet 359:1209–1210
Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Coluzzi F, Vernaglione E, Pelaia P, Pietropaoli P (2004) Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 30:597–604
Westphal M, Bone HG, Van Aken H, Sielenkamper AW (2002) Terlipressin for haemodynamic support in septic patients: a double-edged sword? Lancet 360:1250–1251
Jolley DH, De Keulenaer BL, Potter A, Stephens DP (2003) Terlipressin infusion in catecholamine-resistant shock. Anaesth Intensive Care 31:560–564
Fellahi JL, Benard P, Daccache G, Mourgeon E, Gerard JL (2003) Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin? Ann Fr Anesth Reanim 22:631–634
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was performed in the Intensive Care Unit of the Department of Anesthesiology and Intensive Care of the University of Rome “La Sapienza” and funded by an independent research grant from the Department of Anesthesiology and Intensive Care of the University of Rome “La Sapienza”.
Rights and permissions
About this article
Cite this article
Morelli, A., Ertmer, C., Lange, M. et al. Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better?. Intensive Care Med 33, 1669–1670 (2007). https://doi.org/10.1007/s00134-007-0676-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-007-0676-1